Authors :
Riya; Nikita Kaushik; Parveen Kumari; Sushila
Volume/Issue :
Volume 11 - 2026, Issue 11 - November
Google Scholar :
https://tinyurl.com/pje99syh
DOI :
https://doi.org/10.38124/ijisrt/26nov488
Note : A published paper may take 4-5
working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and
ResearchGate.
Abstract :
Psoriasis is a lifelong, immune-mediated inflammatory skin condition clinically defined by excessive keratinocyte hyperproliferation, profound extravascular dermal angiogenesis, and heavy leukocyte infiltration through the layers of cutaneous tissue [1]. Conventional topical and systemic medications often exhibit severe adverse effects, low drug bioavailability, and significant physical effects to enhance transdermal drug penetration [2]. Nowadays, herbal bioactive components from Capsicum species primarily focused on capsaicinoids, carotenoids, and flavonoids have attracted tremendous medical interest as potential healing agents due to their potent anti-inflammatory, antioxidant, and antiproliferative activities [3]. Although, their medical translation is significantly limited by high lipophilicity, severe local skin infection, and speedy systemic clearance [4]. Higher nanotechnology-primarily based delivery methods including strong lipid nanoparticles, polymeric nanogels, nano emulsions, steel/metallic-oxide green-synthesized nanoparticles offer a remarkable opportunity to cross these pharmacological roadblocks [5]. This exhaustive review offers an in-intensity, multifaceted evaluation of Capsicum phytochemistry, the pathophysiological rationale for focus on psoriasis, higher components techniques, mechanistic opinions, and translational clinical prospects documented number one medical literature [6].
References :
- Biancheri, P., et al. (2015). Immunology of psoriasis and inflammatory skin problems. journal of Investigative Dermatology, a hundred thirty five(2), 345–352.
- Krueger, G., et al. (2020). healing management of continual plaque psoriasis. New England journal of medication, 323(20), 1945–1952.
- Yadav, T. (2024). Treatment of psoriasis with herbal components and nano-companies. Bio Impacts, 14(3), 112–128.
- Bernstein, J. E., et al. (1986). results of topically carried out capsaicin on average and intense psoriasis vulgaris. magazine of the Yankee Academy of Dermatology, 15(3), 504–507.
- Parveen, S. R. (2026). dealing with psoriasis with Nature: A guide to Medicinal plant life. Intech Open, 1(1), 1–25.
- Ellis, C. N., et al. (1993). A twin blind evaluate of topically administered capsaicin in pruritic psoriasis. journal of the Yankee Academy of Dermatology, 29(3), 438–442.
- Raval, okay., et al. (2025). Bio-stimulated inexperienced Synthesis of Nanoparticles for Psoriasis treatment. Asian journal of inexperienced Chemistry, 9(four), 373–403.
- Guzmán, I., & Bosland, P. W. (2017). Sensory houses of Capsicum species and phytochemical characterization. meals Chemistry, 221, 1030–1037.
- Materska, M. (2014). Bioactive compounds in Capsicum fruits: Phenols, flavonoids and antioxidant pastime. Nutrition, 6(8), 3241–3258.
- Orellana-Escobedo, L., et al. (2013). Carotenoids and capsaicinoids in chili peppers. journal of Agricultural and meals Chemistry, sixty one(12), 2912–2918.
- Srinivasan, k. (2016). organic sports of chili peppers (Capsicum species) and their lively materials. essential Reviews in food technological know-how and nutrition, 56(7), 1072–1096.
- Luo, X., et al. (2021). Phytochemical ingredients and organic homes of domesticated Capsicum species. Molecules, 26(18), 5520–5535.
- Szallasi, A., & Blumberg, P. M. (1999). Vanilloid (capsaicin) receptors and mechanisms. Pharmacological reviews, fifty one(2), 159–212.
- Holzer, P. (1991). local effector functions of capsaicin-touchy sensory nerve endings. Neuroscience, 48(4), 739–768.
- Roper, J., et al. (2018). Topical capsaicin in dermatology: Mechanism of motion and clinical application. Dermatologic therapy, 31(four), e12613.
- Pazar, N., et al. (2012). Medicinal plant life within the treatment of psoriasis. skin Pharmacology and body structure, 25(4), 162–169.
- Müller, M., et al. (2019). Oxidative pressure and antioxidant therapy in psoriasis. journal of Dermatological technology, ninety four(2), one hundred forty–149.
- Keck, C. M., & Müller, R. H. (2006). Nanostructured lipid vendors (NLC) as a singular transport machine for topical utility. European magazine of Pharmaceutics and Biopharmaceutics, sixty two(2), 149–157.
- Bodmeier R. (1995). Polymeric nanoparticles and nanogels in dermal drug transport. expert Opinion on therapeutic Patents, 5(8), 811–820.
- Kreuter, J. (2004). Nanoparticles—a historical attitude. international journal of Pharmaceutics, 270(1-2), three–10.
- Agnihotri, S. A., et al. (2004). recent advances on chitosan-based micro- and nanoparticles in drug delivery. magazine of managed release, one hundred(1), five–28.
- Lawrence, M. J., & Rees, G. D. (2000). Microemulsion-based totally media as novel drug transport structures. superior Drug transport evaluations, forty five(1), 89–121.
- Mittal, G., et al. (2020). Nano emulsions: An efficient method for focused pores and skin transport of therapeutics. Colloids and Surfaces B: Bio interfaces, 188, 110756.
- Sharma, A., et al. (2024). inexperienced synthesis of silver nanoparticles the use of plant extracts for biomedical purposes. substances science and Engineering: C, 134, 112678.
- Patra, J. ok. et al. 2018. green synthesis of steel nanoparticles via plant extracts and their biological packages. Biotechnology Advances, 36(8): 2133-2150.
- Lowes, M. A. et al. 2007. Pathogenesis of psoriasis. Annual overview of Immunology, 25: 407-435.
- Nestle, F. O. et al. 2009. Psoriasis. New England magazine of drugs, 361(5): 496-509.
- Griffiths, C. E. M. and Barker, J. N. W. N. 2007. Pathogenesis and clinical functions of psoriasis. The Lancet, 370(9583): 263-271.
- Schön, M. P. and Boehncke, W. H. 2005. Psoriasis. New England magazine of medication, 352(18): 1899-1912.
- Boehncke, W. H. and Schön, M. P. 2015. Psoriasis. The Lancet, 386(9997): 983-994.
- Armstrong, A. W. and study, C. 2020. Pathophysiology, scientific presentation, and treatment of psoriasis. JAMA, 323(19): 1945-1960.
- Menter, A. et al. 2019. hints of take care of the management of psoriasis and psoriatic arthritis. magazine of the American Academy of Dermatology, eighty(3): 773-795.
- Langley, R. G. et al. 2005. Psoriasis: Epidemiology, scientific features, and systemic treatment. Annals of the Rheumatic sicknesses, 64(supply 2): ii18-ii23.
- Chiang, C. C. et al. 2013. Antioxidant properties of Capsicum extracts in dermal irritation. journal of Ethnopharmacology, 148(2): 487-495.
- Howard, L. R., et al. (2000). Antioxidant potential and phenolic content material in peppers as stricken by maturity and species. magazine of Agricultural and meals Chemistry, 48(3), 624–631.
- Marin, A., et al. (2004). variations in carotenoid and capsaicin contents in chili peppers. magazine of Agricultural and meals Chemistry,52(15), 4857–4864.
- Conforti, F., et al. (2007). Capsicum species: Antioxidant and anti inflammatory sports. meals Chemistry, 104(4), 1572–1579.
- Prasad, B. C., et al. (2006). anti inflammatory results of capsaicinoids in cutaneous fashions. EU journal of Pharmacology, 530(1-2), 158–165.
- Kawada, T., et al. (1988). results of capsaicin on lipid metabolism and inflammation. journal of nutrition, 118(1), 22–28.
- Zhang, X., et al. (2022). Nanocarrier-primarily based herbal drug transport for psoriasis therapy. international journal of Pharmaceutics, 614, 121450.
- Kumar, R., et al. (2023). Lipid-based nanocarriers for dermal drug delivery: contemporary popularity and destiny prospects. journal of controlled release, 352, 450–472.
- Gupta, M., et al. (2021). Phytochemical-loaded nanoparticles in dermatology. Phytomedicine,85, 153540.
- Singh, V., et al. (2022). green nanotechnology in pharmaceutical drug transport. Nanoscale, 14(10), 3800–3820.
- Verma, D. D., et al. (2003). coaching and characterization of stealth lipid nanoparticles as drug carriers. magazine of controlled release,85(1-3), 233–240.
- Mezei, M., & Kulasekhara, V. (1980). Liposomes—a selective drug transport system for the topical direction of management. magazine of Pharmacy and Pharmacology, 32(1), 666–667.
- Pouton C. W. (2006). method of lipid-primarily based shipping structures for oral and topical management. EU journal of Pharmaceutical Sciences, 29(3-4), 278–287.
- Barry, B. W. (2001). Novel mechanisms and devices to permit a success transdermal drug shipping. EU magazine of Pharmaceutical Sciences, 14(2), one hundred and one–114.
- Benson, H. A. E. (2005). Transdermal drug shipping: Penetration enhancement strategies. cutting edge Drug delivery, 2(1), 23–33.
- Had graft, J. (1999). Passive enhancement techniques in topical and transdermal drug shipping. international journal of Pharmaceutics, 184(1), 1–6.
- Schaefer, H., & Rademeyer, T. E. (1996). skin Barrier: suggestions of Percutaneous Absorption. Karger Publishers.
- Rolland, A., et al. (1993). website-particularly drug delivery to the skin the use of novel vendors. Pharmaceutical reviews, 10(12), 1738–1744.
- Touitou, E., et al. (2000). Ethosomes—novel vesicular vendors for more suitable shipping: Characterization and pores and skin penetration residences. magazine of managed release, sixty five(3), 403–418.
- Cevc, G., & Blume, G. (2001). New, rather green formulation of diclofenac for the topical, transdermal management in ultra deformable drug carriers, Transferosomes. Biochemical, Biophysical Acta, 1564(1), 18–30.
- El Maghraby, G. M., et al. (2008). Liposomes and pores and skin: From drug shipping to model membranes. ecu magazine of Pharmaceutics and Biopharmaceutics, sixty eight(2), 207–215.
- Tan, M. H., et al. (2011). Recent tendencies in liposomal drug delivery structures. Nanomedicine, 6(3), 519–542.
- 56.Alkilani, A. Z., et al. (2015). Transdermal drug delivery: progressive mechanisms and destiny potential. Pharmaceutics, 7(4), 438–474.
- Brown, M. B., et al. (2006). Dermal and transdermal drug shipping programs: recent and future perspectives. drug shipping,13(3), 175–187.
- Priessnitz, M. R., & Langer, R. (2008). Transdermal drug shipping. Nature Biotechnology, 26(11), 1261–1268.
- Roberts, M. S., et al. (2002). Topical and transdermal shipping: procedures, integration, and mathematical types. recent day Drug shipping, 1(1), 1–15.
- Walters, okay. A., & Had graft, J. (1993). Pharmaceutical pores and skin Penetration Enhancement. Marcel Dekker.
- Keith, A. D. (1983). Polymer-mediated dermal shipping constructions. Drug improvement and commercial Pharmacy, nine(four), 653–668.
- Sensible, D. L. (2000). manual of Pharmaceutical managed release technology. Marcel Dekker.
- Florence, A. T. (2005). Nanoparticles and microparticles as drug carriers. Pharmaceutical information, 12(three), 160–166.
- Kreuter, J. (1994). Colloidal Drug shipping structures. Marcel Dekker.
- Cuignet, O., et al. (2011). Pharmacokinetics of topical nanocarriers in psoriasis models. Experimental Dermatology, 20(five), 410–416.
- Wilschut, J., & Hoekstra, D. (2002). Membrane Fusion. CRC Press.
- Jain, A., et al. (2015). Chitosan-based nanocarriers for localized drug shipping. Carbohydrate Polymers, 131, 350–361.
- Sinha, V. R., et al. (2004). Chitosan-based totally microspheres as a drug transport machine. magazine of managed launch, ninety nine(2), 255–271.
- Agrawal, A., et al. (2019). Silk fibroin biomaterials for tissue engineering and drug delivery. advanced Drug delivery critiques, a hundred and forty, a hundred and ten–a hundred thirty five.
- Kundu, S. C., et al. (2008). organic silk fibroin proteins for drug delivery. progress in Polymer technology, 33(10), 998–1018.
- Vyas, S. P. & Khar, R. k. (2002). concentrated and managed Drug shipping: Novel carrier systems. CBS Publishers.
- Vyas, S. P., et al. (2006). layout of novel lipid-primarily based carriers for dermal transport. journal of Drug concentrated on, 14(5), 291–305.
- Rawat, M., et al. (2008). Lipid carriers: a versatile delivery automobile for proteins and peptides. biological & Pharmaceutical Bulletin, 31(eleven), 2045–2051.
- Muller, R. H., et al. (2002). strong lipid nanoparticles (SLN) and nanostructured lipid providers (NLC) for beauty and dermatological arrangements. advanced Drug delivery reviews, fifty four(supply 1), S131–S155.
- Jenning, V., et al. (2000). nutrition A loaded solid lipid nanoparticles for topical use: Drug release homes. magazine of managed release, sixty six(2-3), 115–126.
- Souto, E. B. & Muller, R. H. (2008). research of the elements affecting the incorporation of active ingredients in SLN and NLC. journal of Microencapsulation, 25(7), 443–452.
- Wissing, S. A. & Muller, R. H. (2003). cosmetic packages for strong lipid nanoparticles (SLN). international journal of beauty technological know-how, 25(1-2), 15–24.
- Westesen, k., et al. (1993). investigation of the physicochemical properties of lipid nanoparticles. international magazine of Pharmaceutics, 93(1-3), 189–199.
- Zur Muhle, A., et al. (1998). solid lipid nanoparticles (SLN) for managed drug delivery: Drug release and interplay with matrix lipids. ecu journal of Pharmaceutics and Biopharmaceutics, 45(2), 149–a hundred and fifty five.
- Bunjes, H., et al. 2001. strong lipid nanoparticles: a shut examine the lipid base and the drug incorporation mechanism. complicated Drug shipping studies, 47(1), 19–35.
- Gohla, S. R. & Dingler, A. 2001. the use of sturdy lipid nanoparticles (SLN) in cosmetic preparations. applied Microbiology and Biotechnology, fifty five(4), 395–401.
- Mehnert, W. & Mader, k. 2001. sturdy lipid nanoparticles: creation, characterization and packages. superior Drug delivery evaluations, forty seven(2-three), a hundred sixty five–196.
- Gasco, M. R. 1993. strong lipid nanoparticles for dermal transport. magazine of Pharmacy and Pharmacology, 45(6), 493–498.
- Trotta, M., et al. 2003. sturdy lipid nanoparticles as providers for topical management of tretinoin. international magazine of Pharmaceutics, 257(1-2), 87–ninety five.
- Cavalli, R., et al. 2006. sturdy lipid nanoparticles as carriers for hydrocortisone. worldwide journal of Pharmaceutics, 137(1), 89–96.
Psoriasis is a lifelong, immune-mediated inflammatory skin condition clinically defined by excessive keratinocyte hyperproliferation, profound extravascular dermal angiogenesis, and heavy leukocyte infiltration through the layers of cutaneous tissue [1]. Conventional topical and systemic medications often exhibit severe adverse effects, low drug bioavailability, and significant physical effects to enhance transdermal drug penetration [2]. Nowadays, herbal bioactive components from Capsicum species primarily focused on capsaicinoids, carotenoids, and flavonoids have attracted tremendous medical interest as potential healing agents due to their potent anti-inflammatory, antioxidant, and antiproliferative activities [3]. Although, their medical translation is significantly limited by high lipophilicity, severe local skin infection, and speedy systemic clearance [4]. Higher nanotechnology-primarily based delivery methods including strong lipid nanoparticles, polymeric nanogels, nano emulsions, steel/metallic-oxide green-synthesized nanoparticles offer a remarkable opportunity to cross these pharmacological roadblocks [5]. This exhaustive review offers an in-intensity, multifaceted evaluation of Capsicum phytochemistry, the pathophysiological rationale for focus on psoriasis, higher components techniques, mechanistic opinions, and translational clinical prospects documented number one medical literature [6].